Frontlight ResearchEarly access
Trial site
Centro Medico Reumatologico - OMI
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Lupus (SLE)1 trial
- Neuroendocrine tumours1 trial
- Systemic sclerosis (scleroderma)1 trial
- Phase
- Phase 32 trials
- Phase 21 trial
- Status
- Recruiting3 trials
- Lead sponsor
- Boehringer Ingelheim3 trials
Running trials
Recruiting
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lupus (SLE)1 recruiting
- Neuroendocrine tumours1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026